SEC 13F Intelligence

Exome Asset Management LLC / CTMX

Exome Asset Management LLC’s Cytomx Therapeutics Inc. Position

Does Exome Asset Management LLC own Cytomx Therapeutics Inc. (CTMX)? Yes521.5K shares worth $2M (+1.27% of its 13F portfolio) as of Q1 2026, down from 745.3K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
521.5K
% of Portfolio
+1.27%
Quarters Held
3
currently held

Position History CTMX

Reported value by quarter
Q3 ’25: $2MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026521.5K$2M+1.27%
Q4 2025745.3K$3M+1.52%
Q3 2025745.3K$2M+1.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of CTMX.